Naglazyme

E2210244 UNEXPLORED

Naglazyme is an enzyme replacement therapy used to treat mucopolysaccharidosis VI (Maroteaux–Lamy syndrome), a rare inherited lysosomal storage disorder.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Naglazyme canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

BioMarin Pharmaceutical → hasProduct → Naglazyme ⓘ